The House unanimously passed the Accelerating Access to Dementia & Alzheimer's Provider Training (AADAPT) Act on July 20, 2026, moving it one step closer to law, according to the Alzheimer's Association announcement. For Medicare families, the measure aims to strengthen dementia care in primary care settings. The AADAPT Act is H.R.
3747, a bipartisan bill led by Reps. Troy Balderson, Nanette Barragan, Darin LaHood and Paul Tonko. It focuses on training primary care providers to detect, diagnose, treat and plan care for Alzheimer's and other dementias.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Read the official guidance from House — Use this primary source to verify the official guidance.
- Read the official guidance from Govinfo — Use this primary source to verify the official guidance.
Table of Contents
- What would the bill do?
- Which practices is it designed to reach?
- Why does earlier diagnosis matter for families?
- Is it law yet, and what comes next?
What would the bill do?
The bill would amend the Public Health Service Act to reauthorize the Project ECHO Grant Program and create grants focused on Alzheimer's and other dementias, as shown in the bill text from the Library of Congress. Project ECHO is a remote education model for clinicians.
The program would fund free, remote continuing education that connects primary care providers with dementia-care experts through video conferencing. That structure lets a local doctor consult specialists without sending every patient to a distant clinic.
Which practices is it designed to reach?
It especially targets primary care practices in rural and medically underserved communities, according to the House sponsor's announcement. Many families in these areas face long travel times for specialty memory care.
The goal is better local detection, diagnosis, treatment and care planning. A family doctor could recognize early cognitive change, begin workup and coordinate next steps closer to home.
Why does earlier diagnosis matter for families?
Earlier diagnosis can speed access to treatment, future planning and ongoing care. It also helps families arrange support, finances and daily routines sooner.
For Medicare families, that can mean care closer to home rather than a late referral to a distant specialist. It keeps the trusted primary care office at the center of the process.
Is it law yet, and what comes next?
House passage is not enactment. The Senate companion, S.
4036, was introduced March 10, 2026 and referred to the HELP Committee, with no Senate passage documented in the introduced Senate bill record. Families do not need to apply for anything now. A practical step is to ask a primary care office how it screens for memory concerns and where it refers patients for full diagnosis.
You Might Also Like
- The Third FDA-Cleared Alzheimer’s Blood Biomarker Test in 2026: A Source-Checked Briefing for Younger-Onset Alzheimer’s Families
- Tauklarify Imaging for Alzheimer’s Tau Tangles in 2026: A Source-Checked Briefing for Younger-Onset Alzheimer’s Families
- PrecivityAD2 and Younger-Onset Alzheimer’s Diagnosis in 2026: A Source-Checked Briefing for Younger-Onset Alzheimer’s Families
